Searched for
ORCHID AUROBINDO PHARMA
Stock market update: Nifty Pharma index falls 0.61%The Nifty Pharma index closed 0.61 per cent down at 21393.3.- Stock market update: Nifty Pharma index falls 0.61%The Nifty Pharma index closed 0.61 per cent down at 21393.3.
- Stock market update: Nifty Pharma index advances 0.93% in an upbeat marketThe Nifty Pharma index was trading 0.93 per cent up at 18005.65.
- Stock market update: Nifty Pharma index falls 0.75%The Nifty Pharma index closed 0.75 per cent down at 13510.3.
- Stock market update: Nifty Pharma index falls 0.58% in a weak marketThe Nifty Pharma index was trading 0.58 per cent down at 13534.6.
- Stock market update: Nifty Pharma index falls over 1%; Lupin slips over 2%The index was trading 1.3 per cent down at 11856.4.
- Stock market update: Nifty Pharma index slips nearly 3%; Divi's Lab falls 4%The index was trading 2.64 per cent down at 11862.55.
- Blackstone, Strides, Nectar lead race for Orchid PharmaShares of Orchid closed at Rs 17 on Friday, down 5 per cent.
- Aurobindo, Dr Reddy's Laboratories frontrunners to buy out bankrupt Orchid PharmaOrchid was on the Reserve Bank of India's second list of 28 defaulters that had to be referred to the NCLT before December 31 if no resolut...
- Lenders of Orchid Pharma appoint Sripatham Ramkumar as resolution professionalLakshmi Vilas Bank has referred Orchid Pharma to National Company Law Tribunal and the court had admitted the company on August 17.
- PE funds, domestic pharma companies eye Orchid Pharma under IBCIn August, the NCLT Chennai had given the nod for insolvency proceedings against the company based on a plea filed by one of the lenders, L...
- Taro Q4 results spook pharma majors, shares tankSun pharma and Divi’s Labs settled lower by 3.17 per cent and 3.29 per cent, respectively.
- Pharma body Pharmexcil slams green groups' superbug chargesIn the recent past, much of adverse propaganda is taking place against the Indian companies with an intention to malign the image of Indian...
- Environmental lobby groups blame production methods of drug companies for rise in drug-resistant bacteriaThe Pharmaceuticals Export Council of India (Pharmexcil) set up by the Ministry of Commerce and Industry under foreign trade policy on Thur...
- 3 Indian Pharma cos breeding drug-resistant Bacteria: ReportThe investigation revealed that out of the 34 sites tested across India and China, 16 were found to be harbouring bacteria resistant to ant...
- Pharma stocks probably less risky: Prateek AgarwalPharmaceuticals are probably less risky and to our mind better place than some of the other areas in the market at this point in time.
- Avoid Orchid Chemicals: Deepak MohoniNow if there is a market reversal sometime, the heavyweights would not fall so quickly.
- Orchid, Glenmark, Lupin & Aurobindo Pharma get US nod for LevetiracetamOrchid Pharmaceuticals, Glenmark Pharmaceuticals, Lupin and Aurobindo Pharmaceuticals have all received US FDA approval for their abbreviat...
- Cos convert FCCBs at steep discountsThe recent phase of bullishness notwithstanding India Inc is in for a spot of bother what with many corporates having to convert their fore...
- Global pharma cos may pop in buyout pillThe high-profile Mylan-Matrix deal is likely to trigger a series of mergers and acquisitions (M&A) in the Indian pharmaceutical market. Aro...
Load More- Stock market update: Nifty Pharma index falls 0.75%
